Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors.
Konkle BA, Nelson C, Forsyth A, Hume E
Haemophilia 2002;8(5):706-710.
Review by Aldouri M
Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors.
Mauser-Bunschoten EP, Koopman MMW, Goede-Bolder ADE, et al.
Haemophilia 2002;8(5):649-656.
Review by M. Aldouri
Orthopaedic surgery in haemophilic patients with inhibitors: an overview.
Hvid I, Rodriguez-Merchan EC
Haemophilia 2002;8(3):288-291.
Review by
Continuous infusion of coagulation factor products.
Stachnik JM, Gabay MP
Ann Pharmacother 2002;36(5):882-891.
Review by
Experience with use of recombinant activated factor VII.
Divanon F, Hecquard C, Borel-Derlon A
J Clin Pharm Ther 2002;27(2):133-138.
Review by
Mechanism of factor VIIa-dependent coagulation in hemophilia blood.
Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG
Blood 2002;99(3):923-930.
Review by
Use of recombinant factor VIIa in hereditary bleeding disorders.
Poon MC
Curr Opin Hematol 2001;8(5):312-318.
Review by M. Aldouri
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659